Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
22.2M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
24.7K
-
Shares change
-
-52.2K
-
Total reported value, excl. options
-
$7.99M
-
Value change
-
-$16.9M
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$322.89
Significant Holders of BIO-RAD LABORATORIES, INC. - Common (BIO) as of Q4 2023
6 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Common as of Q4 2023.
BIO-RAD LABORATORIES, INC. - Common (BIO) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7K shares
of 22.2M outstanding shares and own 0.11% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.39M shares), BlackRock Inc. (1.47M shares), Veritas Asset Management LLP (1.08M shares), STATE STREET CORP (875K shares), UBS ASSET MANAGEMENT AMERICAS INC (503K shares), GEODE CAPITAL MANAGEMENT, LLC (460K shares), Invesco Ltd. (458K shares), ALLIANCEBERNSTEIN L.P. (442K shares), EARNEST PARTNERS LLC (394K shares), and BANK OF AMERICA CORP /DE/ (388K shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.